Yu-Chen Li Selected Research

tubulosine

9/2019

Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Chen Li Research Topics

Disease

8	Neoplasms (Cancer) 12/2020 - 01/2007
3	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2011
2	Heart Failure 07/2021 - 01/2021
2	Rheumatoid Arthritis 07/2021 - 01/2021
2	Triple Negative Breast Neoplasms 12/2020 - 01/2020
2	Inflammation (Inflammations) 09/2019 - 01/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012 - 08/2009
1	Bacterial Infections (Bacterial Infection) 03/2022
1	Dysbiosis 03/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2022
1	Pre-Eclampsia (Preeclampsia) 10/2021
1	Cardiotoxicity 07/2021
1	Coronary Disease (Coronary Heart Disease) 07/2021
1	Neuralgia (Stump Neuralgia) 07/2021
1	Heart Injuries 01/2021
1	Sepsis (Septicemia) 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Skin Diseases (Skin Disease) 01/2016
1	Carcinoma (Carcinomatosis) 10/2013
1	Adenocarcinoma of Lung 09/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2007

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 01/2021 - 01/2020
2	AlkaloidsIBA 07/2021 - 01/2021
2	Immune Checkpoint ProteinsIBA 12/2020 - 01/2020
2	Phenobarbital (Luminal)FDA Link 12/2020 - 01/2020
1	tau Proteins (tau Protein)IBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	Amyloid (Amyloid Fibrils)IBA 03/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	plasma protein Z (protein Z)IBA 10/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2021
1	Analgesics (Analgesic Drugs)IBA 07/2021
1	EndotoxinsIBA 01/2021
1	songorineIBA 01/2021
1	ApelinIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	InterleukinsIBA 09/2019
1	Janus Kinase 2IBA 09/2019
1	Biological ProductsIBA 09/2019
1	tubulosineIBA 09/2019
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 09/2019
1	2- cyclohexylimino- 6- methyl- 6,7- dihydro- 5H- benzo(1,3)oxathiol- 4- oneIBA 01/2016
1	oxathiolIBA 01/2016
1	Tumor Suppressor p53-Binding Protein 1IBA 10/2013
1	PlatinumIBA 10/2013
1	STA 9090IBA 09/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2012
1	geldanamycinIBA 09/2012
1	tanespimycin (17AAG)IBA 09/2012
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2009
1	Phosphotransferases (Kinase)IBA 01/2007
1	N-methylpyrroleIBA 01/2007
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2007
1	Antineoplastic Agents (Antineoplastics)IBA 01/2007
1	2,5- bis(5- hydroxymethyl- 2- selenienyl)- 3- hydroxymethyl- N- methylpyrroleIBA 01/2007

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2013
1	Immunotherapy 01/2020